Bpifrance

Develops an off-the-shelf in vivo immunotherapy platform for solid tumors

Develops monoclonal antibody LYS241 targeting neurovascular pathways for Parkinson's disease and stroke

Develops silicon qubits for dense integration and compatibility with industrial fabrication standards

Develops first- and best-in-class antibody-drug conjugates (ADCs) for cancer treatment

Provides AI-driven decision intelligence platform for boards and senior executives

Provides medical device solutions for women living with polycystic ovary syndrome (PCOS)

Develops functional whey protein ingredients through precision fermentation for food and nutrition manufacturers

Provides a non-human identity security platform to detect and remediate leaked secrets in code

Builds AI data centers and infrastructure for enterprises

Develops small-molecule therapies for targeted protein degradation at the point of synthesis